Science 37 (SNCE) has released an update to notify the public and investors about an entry into a material definitive agreement.
On January 28, 2024, Science 37 Holdings, Inc. entered into a Merger Agreement with eMed, LLC and Marlin Merger Sub Corporation, initiating a tender offer to acquire all outstanding shares of Science 37 at $5.75 per share in cash. Following the tender offer, a merger will occur, making Science 37 a wholly owned subsidiary of eMed. The transaction includes provisions for converting equity awards into cash and contains various covenants, termination rights, and a non-solicitation clause, with the Company’s board unanimously recommending stockholders accept the offer. Supporting Stockholders holding approximately 44% of the Company Shares have agreed to tender their shares.
For further insights into SNCE stock, check out TipRanks’ Stock Analysis page.
